Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Product Liability Litigation Impeding R&D, FDA Commissioner Says

Executive Summary

Pharmaceutical research and development is suffering because of the high cost of product liability litigation, FDA Commissioner McClellan said at a U.S. Chamber of Commerce conference in Washington, D.C. July 15

You may also be interested in...



FDA’s Adverse Event Reporting Rule Would Generate “Noise,” PhRMA Says

FDA's proposed rule on suspected adverse events would generate excess reports without increasing the value of the surveillance, the Pharmaceutical Research & Manufacturers of America says

Rx Pricing Plan Offered By FDA’s McClellan; Industry Must Meet “Challenge”

The pharmaceutical industry must "work harder" to establish equitable pricing models, FDA Commissioner McClellan declared during a Sept. 25 address to the First International Colloquium on Generic Medicine in Cancun, Mexico

Rx Pricing Plan Offered By FDA’s McClellan; Industry Must Meet “Challenge”

The pharmaceutical industry must "work harder" to establish equitable pricing models, FDA Commissioner McClellan declared during a Sept. 25 address to the First International Colloquium on Generic Medicine in Cancun, Mexico

Related Content

UsernamePublicRestriction

Register

PS042174

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel